Eric Parker, Senior Director and Site Lead, Neuroscience at Merck, to Give Featured Presentation at 5th Neurodegenerative Conditions Research and Development (Sept 22-23, 2011 in San Francisco, CA)
Eric Parker, Senior Director and Site Lead, Neuroscience at Merck will give a featured presentation on “Getting to First BACE: Development of BACE Inhibitors for the Treatment of Alzheimer's Disease” at the 5th Neurodegenerative Conditions Research and Development Conference to be held in San Francisco, CA on September 22-23, 2011 by GTC.
Eric Parker, Senior Director and Site Lead, Neuroscience at Merck, to Give Featured Presentation at 5th Neurodegenerative Conditions Research and Development (Sept 22-23, 2011 in San Francisco, CA)
Eric Parker, Senior Director and Site Lead, Neuroscience at Merck will give a featured presentation on “Getting to First BACE: Development of BACE Inhibitors for the Treatment of Alzheimer's Disease” at the 5th Neurodegenerative Conditions Research and Development Conference to be held in San Francisco, CA on September 22-23, 2011 by GTC.
Keith Flaherty, Mass Gen Hospital to Speak at 6th Protein Kinase Conference, May 26-27 2011, Boston
Keith T. Flaherty, M.D., Principal Investigator and Director of Developmental Therapeutics at Massachusetts General Hospital Cancer Center to give keynote presentation titled “Targeting BRAF in Cancer Reveals Unexpected Biology and Points to the Next Generation of Inhibitors” at GTCbio’s 6th Protein Kinases in Drug Discovery Conference on May 26-27, 2011 in Boston, MA
Ray Miller, Global Business Development Manager in Biomaterials and Specialties, at DuPont Applied BioSciences, to Give a Presentation at GTC’s 2nd Annual Biobased Chemicals – Inception to Market Conference on July 7-8, 2011 in San Francisco, CA
Ray Miller will give a presentation on “Launching the Bio-PDO™ Platform – The Sorona® Study”. DuPont is rapidly evolving from a 200+ year old chemicals and materials company to an industrial biotechnology powerhouse.
Susan Schneider, Director, Discovery Medicine, Gsk Ophthalmology, Will Give Featured Presentation at Gtc’s 3rd Ocular Diseases & Drug Discovery Conference, Boston, Ma, May 26-27 2011
Susan Schneider, Ph.D., Director, Discovery Medicine, GSK Ophthalmology will present on Systemic Administration of an Anti-Amyloid Beta Monoclonal Antibody Interferes with the Ocular Pathology of a Mouse Model of Age-Related Macular Degeneration at GTC’s 3rd Ocular Diseases & Drug Discovery Conference on May 26-27, 2011 in Boston, MA.
Barbara Wirostko, Altheos – Presents at 3rd Ocular Diseases & Drug Discovery Conference Boston, MA
Barbara Wirostko, Chief Medical Officer of Altheos, will give featured presentation at GTC’s 3rd Ocular Diseases & Drug Discovery Conference, Boston, MA, May 26-27 2011
Bala Ambati, Associate Professor and Director of Corneal Research at the Moran Eye Center, Will Give Presentation at Gtc’s 3rd Ocular Diseases & Drug Discovery Conference, Boston, Ma, May 26-27 2011
Bala Ambati will present research on a novel endocapsular implant capable of delivering pharmaceuticals to the posterior segment of the eye. Implanted concurrently or subsequent to cataract extraction, the capsule drug ring is capable of delivering Avastin to the retina and choroid at pharmacologically active concentrations.
Marcie Glicksman, Ph.D., Co-Director, Laboratory for Drug Discovery at Harvard Neurodiscovery Center to Give Presentation at GTCbio’s 6th Protein Kinases in Drug Discovery Conference on May 26-27, 2011 in Boston, MA
Marcie Glicksman, Ph.D., Co-Director, Laboratory for Drug Discovery at Harvard Neurodiscovery Center to give presentation on “Protein Kinase Inhibitors for Neurodegenerative Diseases” at GTCbio’s 6th Protein Kinases in Drug Discovery Conference on May 26-27, 2011 in Boston, MA
Riccardo Perfetti, VP from Sanofi-Aventis to Speak at Diabetes Summit March 7-8, 2011 Philadelphia
Riccardo Perfetti, MD, PhD, Vice President, Global Medical Affairs, Diabetes Division at Sanofi-Aventis to give a keynote presentation at GTCbio’s Diabetes Summit taking place on March 7-8, 2011 in Philadelphia, PA.
Molecular Diagnostics Conference to Be Held by GTCbio on March 7-8, 2011 in Philadelphia, PA
GTCbio’s Molecular Diagnostics Conference is to be held this year in Philadelphia, PA on March 7-8, 2011.